Year |
Citation |
Score |
2021 |
Oh S, Cho Y, Chang M, Park S, Kwon H. Metformin Decreases 2-HG Production through the MYC-PHGDH Pathway in Suppressing Breast Cancer Cell Proliferation. Metabolites. 11. PMID 34436421 DOI: 10.3390/metabo11080480 |
0.343 |
|
2021 |
Kim JH, Lee J, Jeong H, Bang MS, Jeong JH, Chang M. Nordihydroguaiaretic Acid as a Novel Substrate and Inhibitor of Catechol Methyltransferase Modulates 4-Hydroxyestradiol-Induced Cyto- and Genotoxicity in MCF-7 Cells. Molecules (Basel, Switzerland). 26. PMID 33916785 DOI: 10.3390/molecules26072060 |
0.479 |
|
2020 |
Kim SD, Kim Y, Kim M, Jeong H, Choi SH, Ryu HW, Oh SR, Lee SW, Li WY, Wu HH, Zhu Y, Wang X, Chang M, Song YS. Estrogenic properties of Prunus cerasoides extract and its constituents in MCF-7 cell and evaluation in estrogen-deprived rodent models. Phytotherapy Research : Ptr. PMID 31908073 DOI: 10.1002/ptr.6604 |
0.433 |
|
2019 |
An BH, Jeong H, Kim JH, Park S, Jeong JH, Kim MJ, Chang M. Estrogen receptor-mediated transcriptional activities of spent coffee grounds and spent coffee grounds compost, and their phenolic acid constituents. Journal of Agricultural and Food Chemistry. PMID 31283213 DOI: 10.1021/acs.jafc.9b02452 |
0.335 |
|
2018 |
Jeong SY, Chang M, Choi SH, Oh SR, Wu HH, Zhu Y, Gao XM, Wang X, Zhang B, Lim DS, Lee JY, Kim SD, Song YS. Estrogenic effects of phytoestrogens derived from Flemingia strobilifera in MCF-7 cells and immature rats. Archives of Pharmacal Research. PMID 29797242 DOI: 10.1007/s12272-018-1027-1 |
0.433 |
|
2016 |
An BH, Jeong H, Zhou W, Liu X, Kim S, Jang CY, Kim HS, Sohn J, Park HJ, Sung NH, Hong CY, Chang M. Evaluation of the Biological Activity of Opuntia ficus indica as a Tissue- and Estrogen Receptor Subtype-Selective Modulator. Phytotherapy Research : Ptr. PMID 26989859 DOI: 10.1002/ptr.5602 |
0.441 |
|
2015 |
Woo YM, Shin Y, Lee EJ, Lee S, Jeong SH, Kong HK, Park EY, Kim HK, Han J, Chang M, Park JH. Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells. Plos One. 10: e0132285. PMID 26158266 DOI: 10.1371/journal.pone.0132285 |
0.314 |
|
2014 |
Liu X, An BH, Kim MJ, Park JH, Kang YS, Chang M. Human glutathione S-transferase P1-1 functions as an estrogen receptor α signaling modulator. Biochemical and Biophysical Research Communications. 452: 840-4. PMID 25218501 DOI: 10.1016/j.bbrc.2014.09.017 |
0.424 |
|
2014 |
Ahn HN, Jeong SY, Bae GU, Chang M, Zhang D, Liu X, Pei Y, Chin YW, Lee J, Oh SR, Song YS. Selective Estrogen Receptor Modulation by Larrea nitida on MCF-7 Cell Proliferation and Immature Rat Uterus. Biomolecules & Therapeutics. 22: 347-54. PMID 25143815 DOI: 10.4062/biomolther.2014.050 |
0.433 |
|
2014 |
Liu X, Nam JW, Song YS, Viswanath AN, Pae AN, Kil YS, Kim HD, Park JH, Seo EK, Chang M. Psoralidin, a coumestan analogue, as a novel potent estrogen receptor signaling molecule isolated from Psoralea corylifolia. Bioorganic & Medicinal Chemistry Letters. 24: 1403-6. PMID 24507928 DOI: 10.1016/j.bmcl.2014.01.029 |
0.494 |
|
2012 |
Seo MJ, Liu X, Chang M, Park JH. GATA-binding protein 1 is a novel transcription regulator of peroxiredoxin 5 in human breast cancer cells. International Journal of Oncology. 40: 655-64. PMID 22020876 DOI: 10.3892/ijo.2011.1236 |
0.333 |
|
2010 |
Peng KW, Chang M, Wang YT, Wang Z, Qin Z, Bolton JL, Thatcher GR. Unexpected hormonal activity of a catechol equine estrogen metabolite reveals reversible glutathione conjugation. Chemical Research in Toxicology. 23: 1374-83. PMID 20540524 DOI: 10.1021/Tx100129H |
0.751 |
|
2008 |
Chang M, Overk CR, Kastrati I, Peng KW, Yao P, Qin ZH, Petukhov P, Bolton JL, Thatcher GR. Estrogenic activity of the equine estrogen metabolite, 4-methoxyequilenin. Advances in Experimental Medicine and Biology. 617: 601-7. PMID 18497087 DOI: 10.1007/978-0-387-69080-3_62 |
0.738 |
|
2007 |
Chang M, Peng KW, Kastrati I, Overk CR, Qin ZH, Yao P, Bolton JL, Thatcher GR. Activation of estrogen receptor-mediated gene transcription by the equine estrogen metabolite, 4-methoxyequilenin, in human breast cancer cells. Endocrinology. 148: 4793-802. PMID 17584965 DOI: 10.1210/En.2006-1568 |
0.742 |
|
2005 |
Kolbanovskiy A, Kuzmin V, Shastry A, Kolbanovskaya M, Chen D, Chang M, Bolton JL, Geacintov NE. Base selectivity and effects of sequence and DNA secondary structure on the formation of covalent adducts derived from the equine estrogen metabolite 4-hydroxyequilenin. Chemical Research in Toxicology. 18: 1737-47. PMID 16300383 DOI: 10.1021/Tx050190X |
0.537 |
|
2005 |
Li Y, Yang X, Chang M, Yager JD, van Breemen RB, Bolton JL. Functional and structural comparisons of cysteine residues in the Val108 wild type and Met108 variant of human soluble catechol O-methyltransferase. Chemico-Biological Interactions. 152: 151-63. PMID 15840388 DOI: 10.1016/J.Cbi.2005.03.001 |
0.595 |
|
2004 |
Li Y, Yao J, Chang M, Cuendet M, Bolton JL. Altered apoptotic response in MCF 10A cells treated with the equine estrogen metabolite, 4-hydroxyequilenin. Toxicology Letters. 154: 225-33. PMID 15501614 DOI: 10.1016/J.Toxlet.2004.08.006 |
0.624 |
|
2004 |
Li Y, Yao J, Chang M, Nikolic D, Yu L, Yager JD, Mesecar AD, van Breemen RB, Bolton JL. Equine catechol estrogen 4-hydroxyequilenin is a more potent inhibitor of the variant form of catechol-O-methyltransferase. Chemical Research in Toxicology. 17: 512-20. PMID 15089093 DOI: 10.1021/Tx0342464 |
0.65 |
|
2003 |
Yao J, Li Y, Chang M, Wu H, Yang X, Goodman JE, Liu X, Liu H, Mesecar AD, Van Breemen RB, Yager JD, Bolton JL. Catechol estrogen 4-hydroxyequilenin is a substrate and an inhibitor of catechol-O-methyltransferase. Chemical Research in Toxicology. 16: 668-75. PMID 12755597 DOI: 10.1021/Tx0340549 |
0.703 |
|
2002 |
Yao J, Chang M, Li Y, Pisha E, Liu X, Yao D, Elguindi EC, Blond SY, Bolton JL. Inhibition of cellular enzymes by equine catechol estrogens in human breast cancer cells: specificity for glutathione S-transferase P1-1. Chemical Research in Toxicology. 15: 935-42. PMID 12119004 DOI: 10.1021/Tx020018I |
0.689 |
|
2001 |
Bolton JL, Chang M. Quinoids as reactive intermediates in estrogen carcinogenesis. Advances in Experimental Medicine and Biology. 500: 497-507. PMID 11764987 DOI: 10.1007/978-1-4615-0667-6_75 |
0.565 |
|
2001 |
Chang M, Shin YG, van Breemen RB, Blond SY, Bolton JL. Structural and functional consequences of inactivation of human glutathione S-transferase P1-1 mediated by the catechol metabolite of equine estrogens, 4-hydroxyequilenin. Biochemistry. 40: 4811-20. PMID 11294649 DOI: 10.1021/Bi002513O |
0.543 |
|
1999 |
Chang M, Bolton JL, Blond SY. Expression and purification of hexahistidine-tagged human glutathione S-transferase P1-1 in Escherichia coli. Protein Expression and Purification. 17: 443-8. PMID 10600464 DOI: 10.1006/Prep.1999.1149 |
0.515 |
|
1998 |
Chang M, Zhang F, Shen L, Pauss N, Alam I, van Breemen RB, Blond SY, Bolton JL. Inhibition of glutathione S-transferase activity by the quinoid metabolites of equine estrogens. Chemical Research in Toxicology. 11: 758-65. PMID 9671538 DOI: 10.1021/Tx9702190 |
0.721 |
|
Show low-probability matches. |